Nippon India Pharma Fund Datagrid
Category Pharma Fund
BMSMONEY Rank -
Rating
Growth Option 11-12-2025
NAV ₹512.18(R) +0.86% ₹572.55(D) +0.86%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular -0.3% 21.43% 15.91% 19.41% 13.49%
Direct 0.61% 22.52% 16.97% 20.48% 14.51%
Nifty Pharma TRI 2.89% 22.23% 13.84% 15.5% 7.91%
SIP (XIRR) Regular 5.16% 14.98% 15.55% 18.8% 17.31%
Direct 6.12% 16.07% 16.6% 19.91% 18.36%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
0.97 0.51 0.87 2.52% 0.17
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
15.22% -16.28% -14.28% 0.87 10.65%
Fund AUM As on: 30/06/2025 8229 Cr
Top Pharma Fund
Fund Name Rank Rating
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
Sbi Healthcare Opportunities Fund -

NAV Date: 11-12-2025

Scheme Name NAV Rupee Change Percent Change
NIPPON INDIA PHARMA FUND - IDCW Option 119.38
1.0100
0.8600%
NIPPON INDIA PHARMA FUND - DIRECT Plan - IDCW Option 169.07
1.4400
0.8600%
Nippon India Pharma Fund-Growth Plan-Growth Option 512.18
4.3500
0.8600%
Nippon India Pharma Fund-Growth Plan-Bonus Option 512.18
4.3500
0.8600%
Nippon India Pharma Fund - Direct Plan Growth Plan - Bonus Option 572.55
4.8800
0.8600%
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option 572.55
4.8800
0.8600%

Review Date: 11-12-2025

Beginning of Analysis

The 4 star rating shows a very good past performance of the Nippon India Pharma Fund in Pharma Fund. The Nippon India Pharma Fund has a Jensen Alpha of 2.52% which is lower than the category average of 3.75%, showing poor performance. The Nippon India Pharma Fund has a Sharpe Ratio of 0.97 which is lower than the category average of 1.03, showing poor performance.
The past performance of the {fund_name_eng} may or may not be sustained in the future. The review is not investment advice nor is it a recommendation to buy or sell funds.
Pharma Mutual Funds

Nippon India Pharma Fund Return Analysis

The Nippon India Pharma Fund has delivered a mixed performance across various time horizons, showcasing both strengths and challenges when compared to its Pharma Fund peers and the Nifty Pharma TRI benchmark. This analysis examines the fund’s returns over periods ranging from one month to ten years, alongside its Systematic Investment Plan (SIP) performance, highlighting its rankings within the Pharma Fund category and its ability to outperform or underperform the benchmark and category averages.

  • The fund has given a return of 0.35%, -0.72 and -0.03 in last one, three and six months respectively. In the same period the category average return was -0.86%, -1.55% and 1.58% respectively.
  • Nippon India Pharma Fund has given a return of 0.61% in last one year. In the same period the Nifty Pharma TRI return was 2.89%. The fund has given 2.28% less return than the benchmark return.
  • The fund has given a return of 22.52% in last three years and rank 7th out of eight funds in the category. In the same period the Nifty Pharma TRI return was 22.23%. The fund has given 0.29% more return than the benchmark return.
  • Nippon India Pharma Fund has given a return of 16.97% in last five years and category average returns is 17.61% in same period. The fund ranked 6.0th out of eight funds in the category. In the same period the Nifty Pharma TRI return was 13.84%. The fund has given 3.13% more return than the benchmark return.
  • The fund has given a return of 14.51% in last ten years and ranked 1.0st out of three funds in the category. In the same period the Nifty Pharma TRI return was 7.91%. The fund has given 6.6% more return than the benchmark return.
  • The fund has given a SIP return of 6.12% in last one year whereas category average SIP return is 6.34%. The fund one year return rank in the category is 6th in 13 funds
  • The fund has SIP return of 16.07% in last three years and ranks 7th in 8 funds. Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has given the highest SIP return (22.29%) in the category in last three years.
  • The fund has SIP return of 16.6% in last five years whereas category average SIP return is 17.93%.

Nippon India Pharma Fund Risk Analysis

  • The fund has a standard deviation of 15.22 and semi deviation of 10.65. The category average standard deviation is 15.48 and semi deviation is 10.78.
  • The fund has a Value at Risk (VaR) of -16.28 and a maximum drawdown of -14.28. The category average VaR is -16.14 and the maximum drawdown is -14.76. The fund has a beta of 0.87 which shows that fund is less volatile than the benchmark.

Standard deviation measures the fund's return volatility and Semi deviation focuses on downside volatility. Value at Risk (VaR) is a measure of the risk of investments. Maximum Drawdown is the maximum loss from a peak to a trough of a portfolio. Beta measures the volatility of the fund compared to the benchmark. A beta of 1 indicates that the fund will move in line with the benchmark. A beta of more than 1 indicates that the fund will be more volatile than the benchmark and vice versa.


  • Very Good Performance in Pharma Fund Category
  • Good Performance in Pharma Fund Category
  • Poor Performance in Pharma Fund Category
  • Very Poor Performance in Pharma Fund Category

    • Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

    Data Source: www.amfiindia.com

    SEBI Categorization


    KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % 0.27 1.85
    -0.97
    		-1.94 | 0.27 1 | 13 Very Good
    3M Return % -0.94 2.55
    -1.87
    		-3.97 | -0.76 3 | 13 Very Good
    6M Return % -0.48 3.80
    0.92
    		-4.25 | 4.23 11 | 13 Average
    1Y Return % -0.30 2.89
    -1.08
    		-6.75 | 4.55 5 | 13 Good
    3Y Return % 21.43 22.23
    22.56
    		20.56 | 27.19 5 | 8 Average
    5Y Return % 15.91 13.84
    16.19
    		14.14 | 18.37 6 | 8 Average
    7Y Return % 19.41 15.50
    20.54
    		19.41 | 22.29 7 | 7 Poor
    10Y Return % 13.49 7.91
    12.29
    		11.30 | 13.49 1 | 3 Very Good
    15Y Return % 15.98 11.48
    15.25
    		13.77 | 16.00 2 | 3 Good
    1Y SIP Return % 5.16
    4.97
    		0.81 | 10.00 4 | 13 Very Good
    3Y SIP Return % 14.98
    16.45
    		14.27 | 21.20 7 | 8 Poor
    5Y SIP Return % 15.55
    16.53
    		14.41 | 20.01 6 | 8 Average
    7Y SIP Return % 18.80
    19.86
    		18.80 | 22.32 7 | 7 Poor
    10Y SIP Return % 17.31
    16.91
    		16.52 | 17.31 1 | 3 Very Good
    15Y SIP Return % 16.48
    15.75
    		14.75 | 16.48 1 | 3 Very Good
    Standard Deviation 15.22
    15.48
    		14.11 | 16.43 3 | 8 Good
    Semi Deviation 10.65
    10.79
    		9.86 | 11.34 3 | 8 Good
    Max Drawdown % -14.28
    -14.76
    		-16.36 | -12.33 3 | 8 Good
    VaR 1 Y % -16.28
    -16.14
    		-19.03 | -13.15 5 | 8 Average
    Average Drawdown % -5.91
    -5.60
    		-7.35 | -4.38 6 | 8 Average
    Sharpe Ratio 0.97
    1.03
    		0.86 | 1.29 5 | 8 Average
    Sterling Ratio 0.87
    0.91
    		0.81 | 1.07 5 | 8 Average
    Sortino Ratio 0.51
    0.55
    		0.46 | 0.67 5 | 8 Average
    Jensen Alpha % 2.52
    3.75
    		0.67 | 7.95 5 | 8 Average
    Treynor Ratio 0.17
    0.18
    		0.15 | 0.23 5 | 8 Average
    Modigliani Square Measure % 23.46
    24.47
    		21.06 | 28.91 5 | 8 Average
    Alpha % -0.08
    0.67
    		-2.22 | 5.40 5 | 8 Average
    Return data last Updated On : Dec. 11, 2025.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Nov. 28, 2025
    KPIs: Key Performance Indicators

    Rotate the phone! Best viewed in landscape mode on mobile.
    KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % 0.35 1.85 -0.86 -1.81 | 0.35 1 | 13 Very Good
    3M Return % -0.72 2.55 -1.55 -3.59 | -0.45 3 | 13 Very Good
    6M Return % -0.03 3.80 1.58 -3.48 | 5.12 11 | 13 Average
    1Y Return % 0.61 2.89 0.20 -5.22 | 5.79 5 | 13 Good
    3Y Return % 22.52 22.23 24.00 22.17 | 28.27 7 | 8 Poor
    5Y Return % 16.97 13.84 17.61 15.77 | 19.42 6 | 8 Average
    7Y Return % 20.48 15.50 22.02 20.48 | 23.62 7 | 7 Poor
    10Y Return % 14.51 7.91 13.42 12.54 | 14.51 1 | 3 Very Good
    1Y SIP Return % 6.12 6.34 2.47 | 11.73 6 | 13 Good
    3Y SIP Return % 16.07 17.90 15.89 | 22.29 7 | 8 Poor
    5Y SIP Return % 16.60 17.93 16.00 | 21.05 7 | 8 Poor
    7Y SIP Return % 19.91 21.33 19.91 | 23.47 7 | 7 Poor
    10Y SIP Return % 18.36 18.04 17.67 | 18.36 1 | 3 Very Good
    Standard Deviation 15.22 15.48 14.11 | 16.43 3 | 8 Good
    Semi Deviation 10.65 10.79 9.86 | 11.34 3 | 8 Good
    Max Drawdown % -14.28 -14.76 -16.36 | -12.33 3 | 8 Good
    VaR 1 Y % -16.28 -16.14 -19.03 | -13.15 5 | 8 Average
    Average Drawdown % -5.91 -5.60 -7.35 | -4.38 6 | 8 Average
    Sharpe Ratio 0.97 1.03 0.86 | 1.29 5 | 8 Average
    Sterling Ratio 0.87 0.91 0.81 | 1.07 5 | 8 Average
    Sortino Ratio 0.51 0.55 0.46 | 0.67 5 | 8 Average
    Jensen Alpha % 2.52 3.75 0.67 | 7.95 5 | 8 Average
    Treynor Ratio 0.17 0.18 0.15 | 0.23 5 | 8 Average
    Modigliani Square Measure % 23.46 24.47 21.06 | 28.91 5 | 8 Average
    Alpha % -0.08 0.67 -2.22 | 5.40 5 | 8 Average
    Return data last Updated On : Dec. 11, 2025.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Nov. 28, 2025
    KPIs: Key Performance Indicators

    Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


    Date Nippon India Pharma Fund NAV Regular Growth Nippon India Pharma Fund NAV Direct Growth
    11-12-2025 512.1817 572.5549
    10-12-2025 507.8291 567.6753
    09-12-2025 508.2588 568.1416
    08-12-2025 509.7895 569.8386
    05-12-2025 515.1984 575.842
    04-12-2025 516.9317 577.7651
    03-12-2025 514.4509 574.9782
    02-12-2025 515.4743 576.1078
    01-12-2025 516.2471 576.9573
    28-11-2025 520.0092 581.1187
    27-11-2025 517.5324 578.3367
    26-11-2025 518.742 579.674
    25-11-2025 514.772 575.2235
    24-11-2025 513.4441 573.7256
    21-11-2025 515.3218 575.7811
    20-11-2025 517.4179 578.1089
    19-11-2025 518.5172 579.3228
    18-11-2025 517.7567 578.459
    17-11-2025 521.1516 582.2375
    14-11-2025 519.1691 579.9792
    13-11-2025 517.3914 577.9789
    12-11-2025 515.0188 575.3141
    11-11-2025 510.7876 570.5733

    Fund Launch Date: 10/May/2004
    Fund Category: Pharma Fund
    Investment Objective: The Fund seeks to invest in pharma sector with focus on important segments of the sector viz Domestic Business, International & CRAMS and include deep value as well as high growth pharma businesses. The fund invests across market capitalization within the sector. It may suit investment horizon of around 2-3 years
    Fund Description: An open ended equity scheme investing in pharma sector
    Fund Benchmark: S&P BSE Healthcare TR
    Source: Fund FactSheet

    Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.